Actively Recruiting
Prevention and Control of Chronic Noncommunicable Diseases in Natural Population in Qianwan New District, Ningbo
Led by RenJi Hospital · Updated on 2024-04-29
30000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
R
RenJi Hospital
Lead Sponsor
N
Ningbo Hangzhou Bay Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying the prevention and control of chronic non-communicable diseases in the natural population of Qianwan District, Ningbo. The goal is to establish a risk prediction system to promote early detection, diagnosis, and treatment of these diseases, ultimately aiming to reduce medical costs and extend life expectancy. This observational study collects comprehensive health and biological data from residents to understand key health factors and develop predictive models. Participants undergo a baseline survey and join a prospective cohort involving questionnaires on physical, psychological, and social health, as well as physical exams including height, weight, blood pressure, and various imaging tests. Biological samples such as blood, urine, and feces are collected for clinical biochemical and multi-omics testing. This data builds a multidimensional platform for disease risk prediction and health status assessment. Participants are followed annually through active and passive methods to monitor disease occurrence, deaths, and migrations. The study measures outcomes including death rates and incidence of cardiovascular and other chronic diseases over four years. The research includes quality control of data collection and aims to provide effective health guidance based on risk stratification. Total participation duration spans from the baseline through ongoing annual follow-up until the study's end in 2027.
CONDITIONS
Brief Title
Cohort in Qianwan New District, Ningbo
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Local permanent residents aged 18 and above, including those with household registration or permanent employment
- No serious physical disability and able to communicate normally
- Voluntary participation with signed informed consent
You will not qualify if you...
- Temporary residents and floating population
- Serious health conditions preventing participation in the survey
- Unwillingness to accept follow-up inspections of the project
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants complete baseline health assessments including questionnaires, physical examinations, clinical biochemical tests, and imaging to collect health status information and biological samples.
1 baseline visit (in-person)
Duration - Up to 4 years
Participants are followed annually through active and passive follow-up to monitor disease occurrence, death, and migration for up to 4 years.
Annual follow-up visits and telephone interviews
Trial Site Locations
Total: 1 location
1
Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Actively Recruiting
Research Team
J
Jun Pu, MD, PhD
W
Wei Zhang, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here